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Background: Illicit drug use/dependence has been recognized as a major problem. Clinical studies demonstrate
that poor sleep quality is associated with increased frequency of drug use and relapse. However, few studies have
addressed the issue of sleep quality among illicit drug dependent subjects.
Methods: This cross-sectional study explored sleep quality in drug dependent subjects in China. We studied 2178
illicit drug dependent subjects from drug rehabilitation centres in Changsha and 2236 non-drug-using subjects, all
of whom completed the self-report Pittsburgh Sleep Quality Index (PSQI).
Results: We found that the prevalence of sleep disturbance was much higher in drug users (68.5%, PSQI >5;
specifically, 80.24% in heroin users, 54.16% in methamphetamine users and 81.98% in ketamine users with PSQI >5)
than non-users (26.4%, PSQI >5). Drug users had approximately twice the sleep latency than nondrug users (37.7
minutes V.S 18.4 minutes). Although drug users and non-users reported similar sleep duration (about 7.4 hours),
drug users showed poorer subjective sleep quality and habitual sleep efficiency. They reported more sleep
disturbance and need for sleep medications, more daytime dysfunction and poorer subjective sleep quality
compared with nondrug users. The total PSQI score positively correlated with the duration of drug use (rp = 0.164,
p < 0.001). We also found a link between sleep problems and cigarette smoking, alcohol drinking, and duration of
drug use.
Conclusions: Poor sleep quality is common among illicit drug dependent subjects. Long-term substance users
had more sleep problems. Future research aiming at quantifying the benefits of treatment interventions should not
neglect the influence of sleep problems. Gaining more insight into the impact of sleep quality on the addiction
treatment could also help to target future intervention measures more effectively.
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Illicit drug abuse and drug addiction have been recog-
nized as major problems such as the increased risk of
spreading HIV and other blood-borne viruses, drug-
related criminal activities, drug-related financial prob-
lems, family issues, and public healthcare expenditures
in our society. Drug abuse has been recognized as a
major problem in China since the 1980s and has quickly
and dramatically increased during the past decade [1].* Correspondence: tangliaoyanhui@gmail.com; liutieq@gmail.com
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unless otherwise stated.Although the actual number of drug addicts in China is
not known, it has the world’s largest population of illicit
drug users [1,2].
Sleeping is one of essential maintenance activities in
every individual’s life. Sleep problems may lead to phys-
ical and mental disorders, and even social disturbances.
For example, poor sleep quality has been associated with
treatment-resistant hypertension [3] and suicidal idea-
tion [4]. Sleep disturbances are common in the general
population [5,6], and more pronounced in drug-using
populations [7-9]. Preclinical studies suggest that chronic
sleep deprivation had effects on drug-seeking and drug-
taking behaviors. It also had an effect on the willingness to
work for drugs, and greatly enhanced response for cocainehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sleep quality was associated with increased frequency of
drug use and relapse [8]. Several studies have reported
sleep problems associated with the use of alcohol [11-14].
There were also some studies of sleep problems in opioid
use and methadone maintenance subjects. Assessing by
the Pittsburgh Sleep Quality Index (PSQI), our prelimin-
ary study with 140 Chinese heroin-dependent patients
found that the majority of them reported poor sleep qual-
ity (96.30% had PSQI ≥ 8) [7]. 96.6% of the drug users in a
30 subjects sample study reported a total PSQI score of 6
or higher, suggestive of poor quality of sleep [15]. 70.2% of
patients had PSQI scores >5 in a 121 heroin addicts who
were receiving MMT sample [16], compared with those
methadone maintenance treatment (MMT) patients who
had history of longer duration of opiate usage and a
shorter period in MMT with no methadone take-home
doses (THD) (80.6%, PSQI > 5). MMT patients who had
two weeks achievement of THD showed lower rates of
poor sleep (56%, PSQI > 5) [17].
According to 2013 National Drug Abuse Monitoring An-
nual Report, the abuse of traditional drugs (mainly heroin)
has been decreased recently. But the abuse of synthetic
drugs (mainly methamphetamine and ketamine) showed a
rising trend (http://www.sda.gov.cn/WS01/CL1404/107039.
html, Chinese). However, little work has been done on
investigating sleep quality in stimulants (mostly meth-
amphetamine, also called “ice”) and ketamine dependent
subjects. The present study aimed to investigate the fre-
quency of poor sleep quality among 2178 illicit drug
dependent subjects and 2236 non drug users, and to
assess the correlation between sleep quality as well as dur-
ation of drug use. Based on previous studies, we hypothe-
sized that most illicit drug dependent subjects would have
poorer sleep quality, and prevalence of poor sleep quality
subjects will be much higher in illicit drug users when
compared with non drug using controls. Duration of sub-
stance abuse may have impact on quality of sleep. Peles E
found that subjects with a longer duration of opiate usage
had poorer sleep [17]. Pasch KE Found a longitudinal bi-
directional relationships between sleep quality and addict-
ive substance use (such as cigarettes, alcohol or marijuana)
[18]. Furthermore, our previous study showed that dur-
ation of ketamine use has been associated with alteration
of brain structure [19]. Thus, we also hypothesized that
self-reported poor sleep quality would be associated with
the longer duration of substance use.
Methods
Design
A cross-sectional descriptive survey design was used to
explore sleep quality in illicit drug (including marijuana)
dependent subjects in two drug rehabilitation centres in
Changsha, China.Subjects
Participants were recruited from November 2010 to April
2014 in Changsha city, Hunan province, China. We re-
cruited 2315 illicit drug dependent subjects from two drug
rehabilitation centres (1949 subjects came from the
Kangda Voluntary Drug Rehabilitation Centre in Hunan
Province and 366 subjects came from the Department of
Addiction Medicine, Hunan Brain Hospital) and 2390
healthy nondrug users with negative illicit drug use test
through a combination of targeted site sampling, advertise-
ment and snowball sampling referrals. Among them, 2178
drug users (1824 subjects came from the KangdaVoluntary
Drug Rehabilitation Centre in Hunan Province and 354
subjects came from the Department of Addiction Medi-
cine, Hunan Brain Hospital) and 2236 nondrug users from
seven communities in Hunan province completed all ques-
tions. Sampling of nondrug users was collected by visiting
demographically matched households. The data of illicit
drug dependent subjects was collected following comple-
tion of a 10-day detoxification-treatment. All these drug
use subjects met the Diagnostic and Statistical Manual of
Mental Disorders, fourth edition criteria for lifetime keta-
mine dependence determined from the Structured Clinical
Interview. Control subjects were included only if they had
never used any drugs. Control subjects were excluded if
they reported major medical or psychiatric disorders.
Assessment measures
In addition to some demographic information, self-
report measure of Pittsburgh Sleep Quality Index (PSQI)
[20] was used. Since its introduction in 1989, the PSQI
had been widely used and well-validated measure of
sleep quality in various cultures. It is a self-rating ques-
tionnaire used to assess subjective sleep quality during
the previous month. It contains 19 self-rated questions,
resulting in both a global score and 7 component sub-
scores: subjective sleep quality, sleep latency, sleep dur-
ation, sleep efficiency, sleep disturbance, use of sleep
medication and daytime dysfunction. Each component
has been scored from 0 to 3, resulting in global PSQI
score between 0 and 21, with higher scores indicating a
lower quality of sleep. A PSQI global score greater than
5 indicates ‘poor sleep’ with a sensitivity of 89.6–98.7%
and specificity of 84.4–86.5% [20,21]. Also, there has a
suggestion of a cut-off of the global score at higher than
8, which means a severe sleep problem [22,23]. The
questionnaire is easy to handle and can be completed
within 5 min. The Chinese language version of PSQI is
well validated, reliable and widely used in patients and
general populations [24,25].
Procedure
Before conducting the study, both the study and oral in-
formed consent were approved from the Second Xiangya
Table 1 Demographic, cigarette smoking and alcohol





Age, M ± SD 30.04 ± 7.134 30.58 ± 11.145
Educational levels, M ± SD* 10.63 ± 2.975 12.10 ± 3.225
Gender (n, %) Male 1875, 86.1% 1910, 85.4%
Female 303, 13.9% 326, 14.6%
Ethnicity (n, %) Han Chinese 2149, 98.8% 2156, 96.5%
Minorities 26, 1.2% 79, 3.5%
Employment status (n, %) Employed 1214, 56.0% 1360,61.1%
Unemployed 953, 44.0% 866, 38.9%
Marital status (n, %) Married 942, 43.3% 1136, 51.5%
Unmarried 1227, 56.6% 1071, 48.5%
Cigarette smoking (n, %) Smokers 2104, 96.7% 895, 40.3%
Nonsmokers 71, 3.3% 1328, 59.7%
Alcohol drinking (n, %) Drinkers 758, 34.9% 686, 30.9%
Nondrinkers 1413, 65.1% 1535, 69.1%
M: mean; SD: standard deviation; n: number; %: the percentage of subjects.
Cigarette smoker was defined as smoked more than 100 cigarettes in the
life time.
Alcohol drinking was defined as drunk no less than 30 g alcohol (equal to
900 ml beer) per week.
* Significantly different from control group, p < 0.01.
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view Board (No.S117, 2009). Drug dependent partici-
pants have been invited to answer the short self-
reported questionnaire on the first week of the adminis-
tration. As part of the consent process, participants were
provided with a detailed explanation of the objectives of
the study and study expectations. Participants were ad-
vised of their ability to withdraw from the study at any
point without penalty or adverse consequences. Issues of
confidentiality and anonymity were discussed. Oral in-
formed consent was obtained. Participants were encour-
aged to answer the questionnaire independently and as
soon as possible.
Statistical analysis
Statistical analysis was performed using the SPSS for
Windows (Version 16, SPSS Inc., Chicago, IL, USA) soft-
ware package. To address missing data, incomplete
questionnaires were excluded. Descriptive statistics were
used to examine demographic characteristics and pooled
responses. Independent sample t-tests were conducted
to determine group differences (drug use and nondrug
use groups) in sleep problems. Correlation between
PSQI total scores and duration of illicit drug use was ex-
plored using the Pearson correlation coefficients. Mul-
tiple linear regression model has been applied to
evaluate the impact of age, gender, number of cigarettes
smoked per day, drinking or not, duration of drug use




2178 subjects in 2315 (94.08%) drug users and 2236 sub-
jects in 2390 (93.56%) nondrug users agreed to partici-
pate in the study and completed all questions. The
overall response rate was 93.82%. The overall sample
group was characterized typically by middle class socio-
economic status. The two groups were age and gender-
matched. Demographic characteristics of illicit drug
users and control subjects are shown in Table 1.
Drug use characteristics
46.5% (1012) mainly heroin users, 44.2% (962) mainly
methamphetamine users, 7.9% (172) mainly ketamine
users, and 1.5% (32) other drug users (including 18 ‘Ma
Gu’ (amphetamine and caffeine), 5 marijuana users, 3
cocaine users, 2 “HuYouyou” (Methaqualone and ephe-
drine), 2 tramadol hydrochloride, 1 dihydroetophine user
and 1 “GHB” (Gamma hydroxybutyrate) user). Most of
“club-drug” users were poly-substance users (used meth-
amphetamine, ketamine, and ‘Ma Gu’). All of the drug
users met criteria for at least one substance abuse or
dependence according to the Diagnostic and StatistcalManual for Mental Disorders, Fourth Edition (DSM-IV)
criteria. The mean duration of drug use (months) was
59.5 ± 52.26 (heroin users: 82.1 ± 60.81, methampheta-
mine users: 36.2 ± 31.44, ketamine users: 56.4 ± 31.319,
others drug users: 56.3 ± 38.05). The quantity and fre-
quency of heroin, methamphetamine and ketamine use
in the last three month before administration was shown
as follow: heroin users used 1.72 ± 0.98 g heroin and
1.06 ± 0.34 times per day; methamphetamine users used
0.61 ± 0.91 g methamphetamine and 2.27 ± 1.13 times
per day; ketamine users used 1.37 ± 1.38 g ketamine
powder and 1.53 ± 0.94 times per day.
Sleeping problems
Analysis of the PSQI revealed that the mean Sleep la-
tency (defined as the amount of time it takes to fall
asleep after the lights have been turned off ) was 37.7 ±
38.624 minutes in drug users and 18.4 ± 23.578 minutes
in nondrug users (p < 0.001); the mean total sleep time
was 7.4 ± 2.140 hours in drug users and 7.3 ± 1.278 hours
in nondrug users (p = 0.101), which is much the same as
the widely accepted norm of 7–8 hours of sleep per
night. Detailed information for score of the PSQI com-
ponents and PSQI total score between drug users and
nondrug users is shown in Table 2. The drug users had
higher scores than nondrug users for seven components
and total scores of PSQI. Daytime dysfunction, sleep
Table 2 Score of the PSQI components and PSQI total
score between drug users and nondrug users
Drug users Non drug
users
P
(n = 2178) (n = 2236)
Subjective sleep quality, M ± SD 1.41 ± 0.897 0.75 ± 0.637 <0.001
Sleep latency, M ± SD 1.43 ± 1.128 0.73 ± 0.724 <0.001
≤15 min, n,% 568, 26.1% 914, 40.9% -
16-30 min, n,% 660, 30.3% 1048, 46.9% -
31-60 min, n,% 400, 18.4% 227, 10.2% -
>60 min, n,% 550, 25.3% 47, 2.1% -
Sleep duration, M ± SD 0.84 ± 0.999 0.74 ± 0.817 <0.001
>7 h, n,% 1095, 50.3% 1081, 48.3% -
5–7 h, n,% 891, 40.9% 1118, 50% -
<5 h, n,% 192, 8.8% 37, 1.7% -
Habitual sleep efficiency*, M ± SD 0.67 ± 1.048 0.30 ± 0.689 <0.001
≥85%, n,% 1420, 65.2% 1779, 79.6% -
75–84%, n,% 329, 15.1% 305, 13.6% -
65–74%, n,% 167, 7.7% 81, 3.6% -
<65%, n,% 262, 12.0% 71, 3.2% -
Sleep disturbance, M ± SD 1.12 ± 0.735 0.70 ± 0.536 <0.001
Need for sleep medications, M ± SD 0.88 ± 1.241 0.06 ± 0.281 <0.001
Not during the past month, n,% 1359, 62.4% 2129, 95.2% -
Less than once a week, n,% 173, 7.9% 88, 3.9% -
Once or twice a week, n,% 185, 8.5% 15, 0.7% -
≥3 times a week, n,% 461, 21.2% 4, 0.2% -
Daytime dysfunction, M ± SD 1.63 ± 1.109 0.91 ± 0.848 <0.001
PSQI total score, M ± SD 7.97 ± 4.392 4.20 ± 2.468 <0.001
Good sleepers (PSQI≤ 5), n,% 686, 31.5% 1645, 73.6% -
Poor sleepers (PSQI > 5), n,% 1492, 68.5% 591, 26.4% -
M: mean; SD: standard deviation; n: number; %: the percentage of subjects.
Mean differences were analyzed between drug users and non drug users by
t-tests; Score ranges from 0 to 3, with higher scores indicating poorer functioning.
Habitual sleep efficiency* = total hours of sleep/(get-up time− bedtime) × 100%.







PSQI > 5 PSQI > 8
n,% n,%
heroin 1012, 46.5% 9.18 ± 4.047 812, 80.24% 559, 55.24%
“ice” 962, 44.2% 6.60 ± 4.476 521, 54.16% 314, 32.64%
ketamine 172, 7.9% 8.75 ± 3.762 141, 81.98% 79, 45.93%
others 32, 1.5% 7.03 ± 3.478 19, 59.36% 7, 21.88%
M: mean; SD: standard deviation; n: number; %: the percentage of subjects.
“ice”: methamphetamine.
Table 4 The PSQI total score between smokers and
nonsmokers, drinkers and nondrinkers among drug users
and non users
Variables PSQI total score
n M ± SD p
Non users Smoking Yes 895 4.38 ± 2.583 0.004
No 1328 4.07 ± 2.378
Alcohol drinking Yes 686 4.57 ± 2.463 <0.001
No 1535 4.03 ± 2.449
Drug users Smoking Yes 2104 7.94 ± 4.427 0.01
No 71 8.94 ± 3.112
Alcohol drinking Yes 758 6.99 ± 5.027 <0.001
No 1413 8.51 ± 3.916
n: number; M: mean; SD: standard deviation.
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sleep problems in drug users.
Subjects were divided into groups of good sleepers
(PSQI ≤ 5) and poor sleepers (PSQI > 5). A majority of
the drug abuse subjects (68.5%) and slightly more than
one fourth (26.4%) nondrug users had a total PSQI score
of 5 or higher, suggestive of mild sleeping problems;
43.9% (956) drug use subjects and 5.2% (117) nondrug
users had PSQI >8, suggestive of poor quality of sleep.
Sleeping quality for difference types of drug users is
shown in Table 3.
Sleep problems and duration of drug use (months)
Pearson correlation analyze was conducted for the correl-
ation of the total PSQI score and the duration of illicitdrug use (months). The total PSQI score positively corre-
lated with the duration of drug use (rp = 0.164, p < 0.001).
Sleep problems among cigarette smokers and
nonsmokers, alcohol drinkers and nondrinkers
T test has been applied for assessing the differences be-
tween cigarette smokers and nonsmokers, alcohol drinkers
and nondrinkers among drug users and nondrug users. In
the nondrug use group, both smokers and alcohol drinkers
had relatively high PSQI total score. However, in the drug
use group, both smokers and alcohol drinkers had rela-
tively low PSQI total score (see Table 4).
Variables (age, gender, number of cigarettes smoked per
day, drinking, duration of drug use) predicting increased
Sleep problems
Multiple linear regression models have been applied to
evaluate the impact of age, gender, number of cigarettes
smoked per day, drinking or not, duration of drug use
on Sleep problems. It showed that age, gender, number
of cigarettes smoked per day, drinking or not, duration
of drug use were related to PSQI total score. In other
words, increased age, female, cigarette smokers who
smoked more cigarettes per day, alcohol drinkers, drug
users with longer-term drug use had more sleep prob-
lems (see Table 5).
Table 5 MLR model predicting increase in PSQI total
score
Variable B 95% Confidence interval p
Age 0.048 0.015 to 0.080 0.004
Gender 1.126 0.422 to 1.830 0.002
Cigarette/day 0.032 0.013 to 0.051 0.001
Drinking or not 0.736 0.264 to 1.209 0.002
Duration of drug use (M) 0.011 0.006 to 0.016 <0.001
Multiple linear regression model (MLR) model.
Y =4.555 + 0.048 age + 1.126 gender + 0.032 cigarette/day + 0.736 drinking +
0.011 duration of drug use (Months).
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We found, as hypothesized, that the prevalence of sleep
disturbance was much higher in drug users (68.5%, PSQI
>5) than nondrug users (26.4%, PSQI >5), and that those
drug users who experienced longer duration of drug use
had poorer sleep quality. In addition, this study found
that drug users (37.7 minutes) had approximate twice
sleep latency than nondrug users (18.4 minutes). Although
drug users and nondrug users reported similar sleep dur-
ation (about 7.4 hours), drug users showed poorer subject-
ive sleep quality and habitual sleep efficiency, more sleep
disturbance and need for sleep medications, more daytime
dysfunction and poorer subjective sleep quality compared
with nondrug users. Furthermore, we found that the total
PSQI score positively correlated with the duration of drug
use (rp = 0.164, p < 0.001); increased age, female, cigarette
smokers who smoked more cigarettes per day, alcohol
drinkers, drug users with longer-term drug use were exhi-
biting high PSIQ total score (more sleep problems).
Sleep problems in illicit drug users
This study showed that a majority of the drug users
(68.5%) had PSQI >5 (suggestive of mild sleeping prob-
lems), which was much higher compared with non drug
users (26.4%); almost half of the drug users (43.9%) had
PSQI >8 (suggestive of poor quality of sleep), and only
5.2% of nondrug users had PSQI >8. High prevalence of
sleep disturbance in this study is consistent with previ-
ous studies. For example, Peles et al. found that 75.2% of
the 101 methadone maintenance treatment patients re-
ported prevalence of sleep disorders (PSQI >5) [26]; in a
cohort of 225 methadone maintenance treatment pa-
tients. Stein et al. found 84% of them reported sleep dis-
turbance (PSQI >5) [27]. Our previous pilot study found
that 134 heroin dependent patients reported sleeping
problems (PSQI >5) among135 subjects [7].
Among the seven components, daytime dysfunction,
subjective sleep quality, and sleep latency were the most
severe sleep problems in drug users. However, Drug
users (0.84 ± 0.999) and nondrug users (0.74 ± 0.817) in
this study reported less significant differences in sleep dur-
ation. The similarity of sleep duration between drug usersand nondrug users contradicted with previous reports and
indicates a need further studies. Sharkey et al. reported
that average sleep times for the diary, morning question-
naire, and polysomnography in opioid dependence were
340, 323, and 332 min, respectively [28]. Chaputa et al.
reported that, when participants were categorized as
short- (⩽6 h), average- (7–8 h) or long- (>8 h) duration
sleepers, short-duration sleepers consumed significantly
more alcohol than the two other sleep-duration groups
[29]. A study from Chakravorty et al. also showed a link
between decreased sleep duration and heavy alcohol
consumption [30]. Palmer et al. found a strong negative
association between cigarette smoking and sleep duration
on both men and women, and between alcohol consump-
tion and sleep duration in men [31]. Smokers also showed
shorter sleep period time [32].
Heroin users had longest mean of duration of drug use
and showed the highest mean of PSQI total score,
followed by ketamine users and users used other drugs.
Compared with them, methamphetamine users used it for
a relatively short period and showed relatively low total
PSQI score. Furthermore, Pearson correlation analyze was
also showed a positive correlation between total PSQI
score and the duration of illicit drug use (months), which
indicated that long-term substance users had more sleep
problems. Linear regression analyze also showed that drug
users with longer-term drug use is associated with more
sleep problems. Lifetime drug use and drug use disorder
may be a proxy for other variables like other chronic mal-
adaptive behaviors, prior trauma, antisocial, borderline
and schizotypal personality disorders [33].
Impact of alcohol drinking and cigarette smoking
on sleep
We found that cigarette smokers who smoked many cig-
arettes per day and alcohol drinkers had more sleep
problems. Cigarette smoking and alcohol drinking are
commonly comorbid with illicit drug use disorders and
may aggravate sleep disturbance [34]. The association
found between sleep problems and alcohol drinking
and cigarette smoking in our study is consistent with
prior literature. Disturbed sleep in alcohol drinkers was
widely studied [35,36]. Alcohol dependent patients who
were smokers showed greater difficulty falling asleep
[34]. Sleep disturbance is also common among cigarette
smokers [37,38] and predicts smoking cessation failure
[39]. A survey with 484 individuals showed that com-
pared with nonsmokers, cigarette smokers reported
more problems going to sleep, problems staying asleep,
and daytime sleepiness [40]. There is also an association
between adolescent smoking and sleep disorders [38]
Our study found an association between number of ciga-
rettes smoked per day and sleep problems (smoked more
cigarettes per day had more sleep problems). However,
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day), but not heavier smoking, was associated with self-
reported sleep problems [41]. Further studies are needed
to clarify the relationship between total number of ciga-
rettes smoked per day and sleep quality.
Sleep problems and clinical implication
The co-occurrence of sleep problems and drug abuse is
clinically significant because previous studies proved that
sleep problems among drug abuse patients have been as-
sociated with subsequent drug relapse [42,43]. Disturbed
sleep is an important predictor of relapse. A line of this
study showed that sleep problems among alcoholic pa-
tients have been significantly associated with subsequent
relapse [11,44]. Self-reported sleep problems can provide
clinicians with information to plan better treatment for
alcohol abusers [13]. Despite the evidence that alcohol-
related sleep disturbances are predictors of relapse, this
area of illicit drug abuse research is still in its infancy.
Since sleep disturbance may as a predictor of treatment
outcome, investigating their role in drug abuse may be
particularly advantageous in furthering our knowledge
about predicting addiction treatment outcome. Prospect-
ive studies are needed in order to verify the correlation
between sleep problems and relapse, such as whether
sleep disturbances during illicit drug withdrawal predict
treatment outcome. Furthermore, impaired sleep may
also contribute to reduced cognitive function [45].
Strengths and limitations of the study
The sample size is relatively large in this study, and the
control group was age and gender matched to the group
of drug users. However, the current study only focused
on sleep status, other factors that can have impact on
sleep quality have not been considered in the study.
Other limitations including collection of data from two
drug rehabilitation centers (it may not be representative
of all illicit drug users) with brief self-administered ques-
tionnaires; lack of objective sleep metrics. All illicit drug
categories have been addressed as one; duration of drug
use (months) may be associated with a recall bias. Also,
the controls were recruited from snowball sampling in
seven communities, and the controls were not matched
for factors as mental health, and prescribed drugs. Fu-
ture work should use the PSQI in longitudinal studies
with more clinical factors and objective sleep metrics,
and special attempts should be made to recruit larger
samples targeting female drug use subjects to further
elucidate the findings of this study.
Conclusion
In conclusion, we found that the prevalence of sleep
disturbance was much higher in drug users than non-
drug users, and that those drug users who had longerduration of drug use showed poorer sleep quality. In
addition, this study found that drug users had approxi-
mately twice the sleep latency that nondrug users exhib-
ited. Although drug users and non-users reported
similar sleep duration, drug users showed poorer sub-
jective sleep quality and habitual sleep efficiency. They
also exhibited more sleep disturbance and need for sleep
medications, more daytime dysfunction and poorer sub-
jective sleep quality compared with nondrug users. We
also found an association between sleep problems and
cigarette smoking, alcohol drinking, and duration of
drug use. This study exemplifies the high prevalence of
poor sleep quality in illicit drug dependent subjects. Fu-
ture researches aim at quantifying the benefits of treat-
ment interventions should not neglect the influence of
sleep problems. Gaining more insight into the impact of
sleep quality on the addiction treatment could also help
to target future intervention measures more effectively.
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